Two large real-world analyses presented at ACTRIMS Forum 2026 shed new light on the multiple sclerosis (MS) care continuum, ...
In February 2026, Immunic, Inc. announced an oversubscribed private placement of pre-funded and common warrants expected to raise up to US$400,000,000, alongside plans to complete late-stage multiple ...
A progressive candidate backed by champions of the left, Sen. Bernie Sanders, I-Vt., and Rep. Alexandria Ocasio-Cortez, D-N.Y., pulled off a major upset victory over the more mainstream frontrunner in ...
Add Yahoo as a preferred source to see more of our stories on Google. Progressive activist Analilia Mejia got a concession from former Rep. Tom Malinowski in the crowded special Democratic primary in ...
Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological conditions, according to a new study that analyzed cryopreserved CSF samples ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new late-breaking data from the Phase III FENtrepid study showing the investigational Bruton's tyrosine kinase (BTK ...
– Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, Ocrevus, in ...
Premise Health and Crossover Health plan to merge, creating a large employer-focused advanced primary care company serving more than 400 organizations and operating 900 clinics across the country.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results